Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

A six-drug treatment for metastatic breast cancer showed promising results with low side effects, especially in premenopausal women.

Docetaxel chemotherapy causes more long-term hair loss and dissatisfaction than paclitaxel.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

ADCs can effectively treat breast cancer but may cause side effects like nausea and hair loss.

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

New treatments are making advanced prostate cancer management more complex but also more hopeful.

The drug combination was safe and showed promise in treating advanced tumors.

Carboplatin-paclitaxel is preferred for advanced lung cancer due to its balance of affordability and patient well-being.

Further testing of paclitaxel poliglumex for this cancer treatment is not justified.

Hormone therapy might be a proactive alternative to watchful waiting for early-stage prostate cancer, potentially improving survival without aggressive treatment downsides.

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

MK-5108 is safe and shows potential against tumors, especially alone.

Combining gemcitabine with paclitaxel is more effective than with pemetrexed for advanced lung cancer.

Temozolomide improves survival in grade III glioma patients without harming quality of life.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

Metyrapone effectively stabilizes severe Cushing's disease symptoms before surgery.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

Quality of life, overall survival, and progression-free survival should be equally prioritized in advanced breast cancer treatment decisions.

Over 30 potential cancer prevention treatments are being tested, with some showing promise in early research.

Docetaxel is effective against various cancers but mainly causes neutropenia.

Sacituzumab Tirumotecan shows promise in treating gynecologic cancers with manageable side effects.

The combination of TACE and Donafenib is effective and tolerable for treating unresectable liver cancer.

TICE salvage chemotherapy is effective for treating germ-cell tumors with poor prognosis.

Patients with advanced breast cancer prioritize quality of life, overall survival, and progression-free survival in treatment decisions.

The treatment is safe and shows promise for metastatic breast cancer.

Etoposide makes radiation therapy more effective against tumors without major side effects.

ADT for prostate cancer may harm the heart, but GnRH antagonists might be safer.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.

Adriamycin and ifosfamide together work best for advanced soft tissue sarcomas.